Literature DB >> 23213189

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

Christopher A Haiman1, Daniel O Stram, Andrew J Vickers, Lynne R Wilkens, Katharina Braun, Camilla Valtonen-André, Mari Peltola, Kim Pettersson, Kevin M Waters, Loic Le Marchand, Laurence N Kolonel, Brian E Henderson, Hans Lilja.   

Abstract

BACKGROUND: A common genetic variant (rs10993994) in the 5' region of the gene encoding β-microseminoprotein (MSP) is associated with circulating levels of MSP and prostate cancer risk. Whether MSP levels are predictive of prostate cancer risk has not been evaluated.
METHODS: We investigated the prospective relationship between circulating plasma levels of MSP and prostate cancer risk in a nested case-control study of 1503 case subjects and 1503 control subjects among black, Latino, Japanese, Native Hawaiian, and white men from the Multiethnic Cohort study. We also examined the ability of MSP to serve as a biomarker for discriminating prostate cancer case subjects from control subjects. All statistical tests are two-sided.
RESULTS: In all racial and ethnic groups, men with lower MSP levels were at greater risk of developing prostate cancer (odds ratio = 1.02 per one unit decrease in MSP, P < .001 in the prostate-specific antigen [PSA]-adjusted analysis). Compared with men in the highest decile of MSP, the multivariable PSA-adjusted odds ratio was 3.64 (95% confidence interval = 2.41 to 5.49) for men in the lowest decile. The positive association with lower MSP levels was observed consistently across racial and ethnic populations, by disease stage and Gleason score, for men with both high and low levels of PSA and across all genotype classes of rs10993994. However, we did not detect strong evidence of MSP levels in improving prostate cancer prediction beyond that of PSA.
CONCLUSIONS: Regardless of race and ethnicity or rs10993994 genotype, men with low blood levels of MSP have increased risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23213189      PMCID: PMC3565627          DOI: 10.1093/jnci/djs486

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  Molecular cloning of human prostate specific antigen cDNA.

Authors:  A Lundwall; H Lilja
Journal:  FEBS Lett       Date:  1987-04-20       Impact factor: 4.124

2.  Crystal structure of the cysteine-rich secretory protein stecrisp reveals that the cysteine-rich domain has a K+ channel inhibitor-like fold.

Authors:  Min Guo; Maikun Teng; Liwen Niu; Qun Liu; Qingqiu Huang; Quan Hao
Journal:  J Biol Chem       Date:  2004-12-13       Impact factor: 5.157

3.  beta-Microseminoprotein binds CRISP-3 in human seminal plasma.

Authors:  Lene Udby; Ake Lundwall; Anders H Johnsen; Per Fernlund; Camilla Valtonen-André; Anna M Blom; Hans Lilja; Niels Borregaard; Lars Kjeldsen; Anders Bjartell
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

4.  Three predominant proteins secreted by the human prostate gland.

Authors:  H Lilja; P A Abrahamsson
Journal:  Prostate       Date:  1988       Impact factor: 4.104

5.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Authors:  Zsofia Kote-Jarai; Ali Amin Al Olama; Graham G Giles; Gianluca Severi; Johanna Schleutker; Maren Weischer; Daniele Campa; Elio Riboli; Tim Key; Henrik Gronberg; David J Hunter; Peter Kraft; Michael J Thun; Sue Ingles; Stephen Chanock; Demetrius Albanes; Richard B Hayes; David E Neal; Freddie C Hamdy; Jenny L Donovan; Paul Pharoah; Fredrick Schumacher; Brian E Henderson; Janet L Stanford; Elaine A Ostrander; Karina Dalsgaard Sorensen; Thilo Dörk; Gerald Andriole; Joanne L Dickinson; Cezary Cybulski; Jan Lubinski; Amanda Spurdle; Judith A Clements; Suzanne Chambers; Joanne Aitken; R A Frank Gardiner; Stephen N Thibodeau; Dan Schaid; Esther M John; Christiane Maier; Walther Vogel; Kathleen A Cooney; Jong Y Park; Lisa Cannon-Albright; Hermann Brenner; Tomonori Habuchi; Hong-Wei Zhang; Yong-Jie Lu; Radka Kaneva; Ken Muir; Sara Benlloch; Daniel A Leongamornlert; Edward J Saunders; Malgorzata Tymrakiewicz; Nadiya Mahmud; Michelle Guy; Lynne T O'Brien; Rosemary A Wilkinson; Amanda L Hall; Emma J Sawyer; Tokhir Dadaev; Jonathan Morrison; David P Dearnaley; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Nicholas Van As; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin S Cooper; Aritaya Lophatonanon; Melissa C Southey; John L Hopper; Dallas R English; Tiina Wahlfors; Teuvo L J Tammela; Peter Klarskov; Børge G Nordestgaard; M Andreas Røder; Anne Tybjærg-Hansen; Stig E Bojesen; Ruth Travis; Federico Canzian; Rudolf Kaaks; Fredrik Wiklund; Markus Aly; Sara Lindstrom; W Ryan Diver; Susan Gapstur; Mariana C Stern; Roman Corral; Jarmo Virtamo; Angela Cox; Christopher A Haiman; Loic Le Marchand; Liesel Fitzgerald; Suzanne Kolb; Erika M Kwon; Danielle M Karyadi; Torben Falck Orntoft; Michael Borre; Andreas Meyer; Jürgen Serth; Meredith Yeager; Sonja I Berndt; James R Marthick; Briony Patterson; Dominika Wokolorczyk; Jyotsna Batra; Felicity Lose; Shannon K McDonnell; Amit D Joshi; Ahva Shahabi; Antje E Rinckleb; Ana Ray; Thomas A Sellers; Hui-Yi Lin; Robert A Stephenson; James Farnham; Heiko Muller; Dietrich Rothenbacher; Norihiko Tsuchiya; Shintaro Narita; Guang-Wen Cao; Chavdar Slavov; Vanio Mitev; Douglas F Easton; Rosalind A Eeles
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

6.  Molecular cloning of a small prostate protein, known as beta-microsemenoprotein, PSP94 or beta-inhibin, and demonstration of transcripts in non-genital tissues.

Authors:  M Ulvsbäck; C Lindström; H Weiber; P A Abrahamsson; H Lilja; A Lundwall
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

7.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

Authors:  L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

8.  Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum.

Authors:  K Mitrunen; K Pettersson; T Piironen; T Björk; H Lilja; T Lövgren
Journal:  Clin Chem       Date:  1995-08       Impact factor: 8.327

9.  A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.

Authors:  Robert K Nam; Jonathan R Reeves; Ants Toi; Helene Dulude; John Trachtenberg; Marjan Emami; Luc Daigneault; Chandra Panchal; Linda Sugar; Michael A S Jewett; Steven A Narod
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

10.  Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.

Authors:  P A Abrahamsson; H Lilja; S Falkmer; L B Wadström
Journal:  Prostate       Date:  1988       Impact factor: 4.104

View more
  18 in total

1.  Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.

Authors:  Adria Closa; David Cordero; Rebeca Sanz-Pamplona; Xavier Solé; Marta Crous-Bou; Laia Paré-Brunet; Antoni Berenguer; Elisabet Guino; Adriana Lopez-Doriga; Jordi Guardiola; Sebastiano Biondo; Ramon Salazar; Victor Moreno
Journal:  Carcinogenesis       Date:  2014-04-23       Impact factor: 4.944

2.  A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.

Authors:  Katharina Braun; Daniel D Sjoberg; Andrew J Vickers; Hans Lilja; Anders S Bjartell
Journal:  Eur Urol       Date:  2015-05-13       Impact factor: 20.096

3.  A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.

Authors:  Melissa Assel; Liisa Sjöblom; Teemu J Murtola; Kirsi Talala; Paula Kujala; Ulf-Håkan Stenman; Kimmo Taari; Anssi Auvinen; Andrew Vickers; Tapio Visakorpi; Teuvo L Tammela; Hans Lilja
Journal:  Eur Urol Focus       Date:  2017-11-11

4.  MALDI-target integrated platform for affinity-captured protein digestion.

Authors:  Asilah Ahmad-Tajudin; Belinda Adler; Simon Ekström; György Marko-Varga; Johan Malm; Hans Lilja; Thomas Laurell
Journal:  Anal Chim Acta       Date:  2013-09-11       Impact factor: 6.558

5.  Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.

Authors:  Eric H Kim; Gerald L Andriole; E David Crawford; Daniel D Sjoberg; Melissa Assel; Andrew J Vickers; Hans Lilja
Journal:  J Urol       Date:  2016-11-01       Impact factor: 7.450

Review 6.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

7.  Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.

Authors:  Peter E Lonergan; Emily A Vertosick; Melissa Assel; Daniel D Sjoberg; Alexander Haese; Markus Graefen; Stephen A Boorjian; George G Klee; Matthew R Cooperberg; Kim Pettersson; Erica Routila; Andrew J Vickers; Hans Lilja
Journal:  BJU Int       Date:  2020-12-28       Impact factor: 5.969

8.  Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Authors:  Elizabeth K Bancroft; Elizabeth C Page; Elena Castro; Hans Lilja; Andrew Vickers; Daniel Sjoberg; Melissa Assel; Christopher S Foster; Gillian Mitchell; Kate Drew; Lovise Mæhle; Karol Axcrona; D Gareth Evans; Barbara Bulman; Diana Eccles; Donna McBride; Christi van Asperen; Hans Vasen; Lambertus A Kiemeney; Janneke Ringelberg; Cezary Cybulski; Dominika Wokolorczyk; Christina Selkirk; Peter J Hulick; Anders Bojesen; Anne-Bine Skytte; Jimmy Lam; Louise Taylor; Rogier Oldenburg; Ruben Cremers; Gerald Verhaegh; Wendy A van Zelst-Stams; Jan C Oosterwijk; Ignacio Blanco; Monica Salinas; Jackie Cook; Derek J Rosario; Saundra Buys; Tom Conner; Margreet G Ausems; Kai-ren Ong; Jonathan Hoffman; Susan Domchek; Jacquelyn Powers; Manuel R Teixeira; Sofia Maia; William D Foulkes; Nassim Taherian; Marielle Ruijs; Apollonia T Helderman-van den Enden; Louise Izatt; Rosemarie Davidson; Muriel A Adank; Lisa Walker; Rita Schmutzler; Kathy Tucker; Judy Kirk; Shirley Hodgson; Marion Harris; Fiona Douglas; Geoffrey J Lindeman; Janez Zgajnar; Marc Tischkowitz; Virginia E Clowes; Rachel Susman; Teresa Ramón y Cajal; Nicholas Patcher; Neus Gadea; Allan Spigelman; Theo van Os; Annelie Liljegren; Lucy Side; Carole Brewer; Angela F Brady; Alan Donaldson; Vigdis Stefansdottir; Eitan Friedman; Rakefet Chen-Shtoyerman; David J Amor; Lucia Copakova; Julian Barwell; Veda N Giri; Vedang Murthy; Nicola Nicolai; Soo-Hwang Teo; Lynn Greenhalgh; Sara Strom; Alex Henderson; John McGrath; David Gallagher; Neil Aaronson; Audrey Ardern-Jones; Chris Bangma; David Dearnaley; Philandra Costello; Jorunn Eyfjord; Jeanette Rothwell; Alison Falconer; Henrik Gronberg; Freddie C Hamdy; Oskar Johannsson; Vincent Khoo; Zsofia Kote-Jarai; Jan Lubinski; Ulrika Axcrona; Jane Melia; Joanne McKinley; Anita V Mitra; Clare Moynihan; Gad Rennert; Mohnish Suri; Penny Wilson; Emma Killick; Sue Moss; Rosalind A Eeles
Journal:  Eur Urol       Date:  2014-01-15       Impact factor: 20.096

9.  Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.

Authors:  Xing Wang; James E Hayes; Xing Xu; Xiaoni Gao; Dipti Mehta; Hans G Lilja; Robert J Klein
Journal:  Gene       Date:  2020-10-26       Impact factor: 3.688

10.  The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects.

Authors:  Deepa R Mhatre; Smita D Mahale; Mohammed I Khatkhatay; Swati K Achrekar; Swapna S Desai; Dhanashree D Jagtap; Jayesh V Dhabalia; Hemant B Tongaonkar; Sucheta P Dandekar; Anand M Varadkar
Journal:  Springerplus       Date:  2015-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.